ANC 0 3 0 3 B-clinical_variable
> 4 5 4 5 O
1,000 6 11 6 11 B-lower_bound

Adequate 0 8 12 20 O
organ 9 14 21 26 O
function 15 23 27 35 O
for 24 27 36 39 O
anthracycline 28 41 40 53 B-treatment
and 42 45 54 57 O
taxane 46 52 58 64 B-treatment
based 53 58 65 70 I-treatment
therapy 59 66 71 78 I-treatment

Creatinine 0 10 79 89 B-clinical_variable
< 11 12 90 91 O
1.5 13 16 92 95 B-upper_bound

Dexlansoprazole 0 15 96 111 B-treatment
( 16 17 112 113 I-treatment
Dexilant 17 25 113 121 I-treatment
) 25 26 121 122 I-treatment

ECOG 0 4 123 127 B-clinical_variable
Performance 5 16 128 139 I-clinical_variable
Status 17 23 140 146 I-clinical_variable
0 24 25 147 148 B-lower_bound
- 25 26 148 149 O
1 26 27 149 150 B-upper_bound

ER 0 2 151 153 B-clinical_variable
and 3 6 154 157 O
PR 7 9 158 160 B-clinical_variable
< 10 11 161 162 O
10 12 14 163 165 B-upper_bound
% 14 15 165 166 I-upper_bound

Esomeprazole 0 12 167 179 B-treatment
( 13 14 180 181 I-treatment
Nexium 14 20 181 187 I-treatment
) 20 21 187 188 I-treatment

HER2 0 4 189 193 O
: 4 5 193 194 O
CEP17 6 11 195 200 B-clinical_variable
ratio 12 17 201 206 I-clinical_variable
< 18 19 207 208 O
2.0 20 23 209 212 B-upper_bound
or 24 26 213 215 O
HER2 27 31 216 220 B-clinical_variable
total 32 37 221 226 I-clinical_variable
copy 38 42 227 231 I-clinical_variable
number 43 49 232 238 I-clinical_variable
< 50 51 239 240 O
6 51 52 240 241 B-upper_bound

Has 0 3 242 245 O
not 4 7 246 249 O
had 8 11 250 253 O
menses 12 18 254 260 O
at 19 21 261 263 O
any 22 25 264 267 O
time 26 30 268 272 O
in 31 33 273 275 O
the 34 37 276 279 O
preceding 38 47 280 289 O
24 48 50 290 292 B-upper_bound
consecutive 51 62 293 304 I-upper_bound
months 63 69 305 311 I-upper_bound

Hgb 0 3 312 315 B-clinical_variable
> 4 5 316 317 O
8.5 6 9 318 321 B-lower_bound

IHC 0 3 322 325 B-clinical_variable
0 4 5 326 327 B-lower_bound
or 6 8 328 330 O
1 9 10 331 332 B-upper_bound
+ 10 11 332 333 I-upper_bound

IHC 0 3 334 337 B-clinical_variable
2 4 5 338 339 B-lower_bound
+ 5 6 339 340 O
and 7 10 341 344 O
FISH 11 15 345 349 B-treatment
equivocal 16 25 350 359 O
and 26 29 360 363 O
no 30 32 364 366 O
indication 33 43 367 377 O
for 44 47 378 381 O
HER2 48 52 382 386 B-treatment
targeted 53 61 387 395 I-treatment
therapy 62 69 396 403 I-treatment
based 70 75 404 409 O
on 76 78 410 412 O
the 79 82 413 416 O
treating 83 91 417 425 O
investigators 92 105 426 439 O
discretion 106 116 440 450 O

IHC 0 3 451 454 B-treatment
2 4 5 455 456 O
+ 5 6 456 457 O
and 7 10 458 461 O
FISH 11 15 462 466 B-treatment
negative 16 24 467 475 O

Known 0 5 476 481 O
hypersensitivity 6 22 482 498 O
to 23 25 499 501 O
any 26 29 502 505 O
component 30 39 506 515 O
of 40 42 516 518 O
the 43 46 519 522 O
formulation 47 58 523 534 O
or 59 61 535 537 O
substituted 62 73 538 549 O
benzimidazoles 74 88 550 564 B-allergy_name

LVEF 0 4 565 569 B-clinical_variable
> 5 6 570 571 O
LLN 7 10 572 575 O
based 11 16 576 581 O
on 17 19 582 584 O
cardiac 20 27 585 592 B-treatment
ECHO 28 32 593 597 I-treatment
or 33 35 598 600 O
MUGA 36 40 601 605 B-treatment

Lansoprazole 0 12 606 618 B-treatment
( 13 14 619 620 O
Prevacid 14 22 620 628 B-treatment
) 22 23 628 629 O

Newly 0 5 630 635 O
diagnosed 6 15 636 645 O
triple 16 22 646 652 B-cancer
negative 23 31 653 661 I-cancer
breast 32 38 662 668 I-cancer
cancer 39 45 669 675 I-cancer
( 46 47 676 677 I-cancer
TNBC 47 51 677 681 I-cancer
) 51 52 681 682 I-cancer
clinical 53 61 683 691 B-clinical_variable
stage 62 67 692 697 I-clinical_variable
Ic 68 70 698 700 B-lower_bound
, 70 71 700 701 O
II 72 74 702 704 O
, 74 75 704 705 O
or 76 78 706 708 O
III 79 82 709 712 B-upper_bound

Omeprazole 0 10 713 723 B-treatment
( 11 12 724 725 O
Prilosec 12 20 725 733 B-treatment
, 20 21 733 734 O
Zegerid 22 29 735 742 B-treatment
) 29 30 742 743 O

Pantoprazole 0 12 744 756 B-treatment
( 13 14 757 758 I-treatment
Protonix 14 22 758 766 I-treatment
) 22 23 766 767 I-treatment

Planned 0 7 768 775 O
neoadjuvant 8 19 776 787 B-treatment
treatment 20 29 788 797 I-treatment
with 30 34 798 802 O
anthracycline 35 48 803 816 B-treatment
and 49 52 817 820 O
taxane 53 59 821 827 B-treatment
containing 60 70 828 838 O
chemotherapy 71 83 839 851 B-treatment

Platelets 0 9 852 861 B-clinical_variable
> 10 11 862 863 O
100,000 12 19 864 871 B-lower_bound

Prior 0 5 872 877 B-treatment
hysterectomy 6 18 878 890 I-treatment

Prior 0 5 891 896 O
osteoporotic 6 18 897 909 B-chronic_disease
fracture 19 27 910 918 I-chronic_disease

Rabeprazole 0 11 919 930 B-treatment
( 12 13 931 932 O
Aciphex 13 20 932 939 B-treatment
) 20 21 939 940 O

T. 0 2 941 943 B-clinical_variable
bili 3 7 944 948 I-clinical_variable
< 8 9 949 950 O
1.3 10 13 951 954 B-upper_bound

Use 0 3 955 958 O
of 4 6 959 961 O
OTC 7 10 962 965 B-treatment
PPIs 11 15 966 970 I-treatment
within 16 22 971 977 O
6 23 24 978 979 B-upper_bound
months 25 31 980 986 I-upper_bound
prior 32 37 987 992 I-upper_bound
to 38 40 993 995 O
study 41 46 996 1001 O
entry 47 52 1002 1007 O

Use 0 3 1008 1011 O
of 4 6 1012 1014 O
Orlistat 7 15 1015 1023 B-treatment
or 16 18 1024 1026 O
any 19 22 1027 1030 O
other 23 28 1031 1036 O
known 29 34 1037 1042 O
FASN 35 39 1043 1047 B-treatment
inhibitor 40 49 1048 1057 I-treatment
within 50 56 1058 1064 O
6 57 58 1065 1066 B-upper_bound
months 59 65 1067 1073 I-upper_bound
prior 66 71 1074 1079 I-upper_bound
to 72 74 1080 1082 O
study 75 80 1083 1088 O
entry 81 86 1089 1094 O

Use 0 3 1095 1098 O
of 4 6 1099 1101 O
prescription 7 19 1102 1114 O
PPIs 20 24 1115 1119 B-treatment
within 25 31 1120 1126 O
12 32 34 1127 1129 B-upper_bound
months 35 41 1130 1136 I-upper_bound
prior 42 47 1137 1142 I-upper_bound
to 48 50 1143 1145 O
study 51 56 1146 1151 O
entry 57 62 1152 1157 O

Women 0 5 1158 1163 B-gender
of 6 8 1164 1166 O
childbearing 9 21 1167 1179 O
potential 22 31 1180 1189 O
definition 32 42 1190 1200 O
must 43 47 1201 1205 O
have 48 52 1206 1210 O
a 53 54 1211 1212 O
negative 55 63 1213 1221 B-pregnancy
pregnancy 64 73 1222 1231 I-pregnancy
test 74 78 1232 1236 O
within 79 85 1237 1243 O
14 86 88 1244 1246 B-upper_bound
days 89 93 1247 1251 I-upper_bound
of 94 96 1252 1254 O
registration 97 109 1255 1267 O

bilateral 0 9 1268 1277 B-treatment
oophorectomy 10 22 1278 1290 I-treatment

â‰¥ 0 1 1291 1292 O
18 2 4 1293 1295 B-lower_bound
years 5 10 1296 1301 I-lower_bound
old 11 14 1302 1305 O
at 15 17 1306 1308 O
the 18 21 1309 1312 O
time 22 26 1313 1317 O
of 27 29 1318 1320 O
informed 30 38 1321 1329 O
consent 39 46 1330 1337 O

